A central mission of the UCLA SPORE in Brain Cancer is to stimulate, recruit, develop, and retain new investigators in the field of brain tumor research, with particular focus on translation of scientific discoveries to novel clinical applications. The future of brain cancer research lies in the continued creation and development of translational projects and innovative investigators at major research institutions, as well as an institutional commitment to support outstanding, dedicated scientists in the field. In order for translational scientists and physician-investigators to grow and flourish, funding support and peer mentorship is imperative. The UCLA SPORE in Brain Cancer Career Enhancement Program (CEP) will provide this research support and mentoring resource, allowing junior faculty to transition to independent investigator status with adequate peer-reviewed funding and established investigators to focus or redirect their research to the area of brain cancer. CEP funds will be designated to prepare investigators for careers in translational brain cancer research and enhance their chances of success in the field. Applications will be accepted from MD, PhD, or MD/PhD advanced post- doctoral fellows who are ready to transition to a faculty position within one year, junior faculty, and established investigators to work with a senior mentor, and special efforts will be made to recruit qualified women, individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities. Applications will be reviewed by the CEP Selection Committee, IAB and EAB members, and ad hoc reviewers with particular areas of expertise. Each year, we anticipate supporting 2 to 3 highly innovative candidates with CEP funds. Ultimately, the CEP is designed to increase scientific inquiry and excellence across the continuum of research on the prevention, early detection, diagnosis and precision therapy for brain cancer.

Public Health Relevance

CEP: Career Enhancement Program NARRATIVE A central mission of the UCLA SPORE in Brain Cancer is to stimulate, recruit, develop and retain new investigators in brain cancer research, with particular focus on translation of scientific discoveries to novel clinical applications. The SPORE Career Enhancement Program will enhance the career development of such new and continuing investigators in the field. Addressing the overall problem of brain cancer will require us to train the next generation of investigators who will focus their career attention on translational/clinical research in the most important aspects of this field.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA211015-03
Application #
9752981
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Majedi, Fatemeh S; Hasani-Sadrabadi, Mohammad Mahdi; Kidani, Yoko et al. (2018) Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T-Cells. Adv Mater 30:
Ellingson, Benjamin M; Abrey, Lauren E; Nelson, Sarah J et al. (2018) Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol 20:1240-1250
Mehta, Shwetal; Lo Cascio, Costanza (2018) Developmentally regulated signaling pathways in glioma invasion. Cell Mol Life Sci 75:385-402
Yang, Jianqiang; Yi, Ning; Zhang, Junhui et al. (2018) Generation and characterization of a hypothyroidism rat model with truncated thyroid stimulating hormone receptor. Sci Rep 8:4004
Chakhoyan, A; Leu, K; Pope, W B et al. (2018) Improved Spatiotemporal Resolution of Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors Using Simultaneous Multi-Slice Echo-Planar Imaging. AJNR Am J Neuroradiol 39:43-45
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395
Nghiemphu, Phioanh Leia; Ebiana, Victoria Asuquo; Wen, Patrick et al. (2018) Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02. J Neurooncol 136:79-86
Yao, Jingwen; Ruan, Dan; Raymond, Catalina et al. (2018) Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography 4:123-137
Yu, Jingyi; Seldin, Marcus M; Fu, Kai et al. (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85
Kong, Xiao-Tang; Nguyen, Nhung T; Choi, Yoon J et al. (2018) Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 100:1195-1203

Showing the most recent 10 out of 91 publications